Search by Drug Name or NDC

    NDC 45802-0846-01 adapalene and benzoyl peroxide .1; 2.5 g/100g; g/100g Details

    adapalene and benzoyl peroxide .1; 2.5 g/100g; g/100g

    adapalene and benzoyl peroxide is a TOPICAL GEL in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Padagis Israel Pharmaceuticals Ltd. The primary component is ADAPALENE; BENZOYL PEROXIDE.

    Product Information

    NDC 45802-0846
    Product ID 45802-846_37897e79-49a5-4230-ba34-bd25f2e7d66d
    Associated GPIs 90059902034020
    GCN Sequence Number 068880
    GCN Sequence Number Description adapalene/benzoyl peroxide GEL W/PUMP 0.1 %-2.5% TOPICAL
    HIC3 L5H
    HIC3 Description ACNE AGENTS,TOPICAL
    GCN 31775
    HICL Sequence Number 036015
    HICL Sequence Number Description ADAPALENE/BENZOYL PEROXIDE
    Brand/Generic Generic
    Proprietary Name adapalene and benzoyl peroxide
    Proprietary Name Suffix n/a
    Non-Proprietary Name Adapalene and Benzoyl Peroxide
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form GEL
    Route TOPICAL
    Active Ingredient Strength .1; 2.5
    Active Ingredient Units g/100g; g/100g
    Substance Name ADAPALENE; BENZOYL PEROXIDE
    Labeler Name Padagis Israel Pharmaceuticals Ltd
    Pharmaceutical Class Retinoid [EPC], Retinoids [CS]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA205033
    Listing Certified Through 2024-12-31

    Package

    NDC 45802-0846-01 (45802084601)

    NDC Package Code 45802-846-01
    Billing NDC 45802084601
    Package 45 g in 1 BOTTLE, PUMP (45802-846-01)
    Marketing Start Date 2018-01-24
    NDC Exclude Flag N
    Pricing Information
    Price Per Unit 0.54728
    Pricing Unit GM
    Effective Date 2024-02-21
    NDC Description ADAPALENE-BNZYL PEROX 0.1-2.5%
    Pharmacy Type Indicator C/I
    OTC N
    Explanation Code 1, 5
    Classification for Rate Setting G
    As of Date 2024-02-21
    This pricing file, entitled the NADAC (National Average Drug Acquisition Cost) files, provide state Medicaid agencies with covered outpatient drug prices by averaging survey invoice prices from retail community pharmacies across the United States. These pharmacies include independent retail community pharmacies and chain pharmacies. The prices are updated on a weekly and monthly basis